Back to events
AACR 2022 Annual Meeting
Posters & Presentations
Evaluation of tissue- and plasma-derived tumor mutational burden and genomic alterations of interest from the CheckMate 848 clinical trial
Lead Author
Jonathan Baden
Collaborator
Bristol Myers Squibb
Date | Time
Monday, April 11 | 2:35 PM - 2:50 PM
Abstract Number
2139
TALAPRO-1: Talazoparib monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with tumor DNA damage response alterations (DDRm)—Exploration of genomic loss of heterozygosity (gLOH) and potential associations with antitumor activity
Lead Author
Johann S. de Bono
Collaborator
Pfizer
Date | Time
Monday, April 11 | 3:20 PM - 3:30 PM
Abstract Number
CT031
Patients with germline ATM mutations develop clonal hematopoiesis characterized by co-occurrence of multiple somatic ATM alterations
Lead Author
Brennan Decker
Date | Time
Sunday, April 10 | 1:30 PM – 5:00 PM
Abstract Number
57/18
Comprehensive genomic profiling (CGP) reveals site-specific enrichment of immunotherapy biomarkers and targetable alterations in non-small cell lung cancer (NSCLC) metastasis
Lead Author
Benjamin G. Kaplan
Date | Time
Monday, April 11 | 9:00 AM – 12:30 PM
Abstract Number
753/9
Comprehensive genomic profiling of tissue and liquid biopsies reveals the landscape of reversion mutations
Lead Author
Shannon T. Bailey
Date | Time
Monday, April 11 | 9:00 AM – 12:30 PM
Abstract Number
798/7
Leveraging existing data to identify ancestry-associated features across multiple cancer types
Lead Author
Jian Carrot-Zhang
Collaborator
Dana Farber Cancer Institute
Date | Time
Monday, April 11 | 9:00 AM – 12:30 PM
Abstract Number
1166/13
Identification of aneuploidy biomarkers associated with response to first-line treatment of metastatic pancreatic cancer
Lead Author
Kuei-Ting Chen
Date | Time
Monday, April 11 | 9:00 AM – 12:30 PM
Abstract Number
1243/15
Development of a pan-cancer algorithm to predict homologous recombination deficiency and sensitivity to PARPi therapy
Lead Author
Emmanuel Antonarakis
Collaborator
University of Minnesota
Date | Time
Monday, April 11 | 9:00 AM – 12:30 PM
Abstract Number
1249/21
Clinical utility of circulating tumor DNA sequencing with a large panel: The experience of Gustave Roussy/ National Center for Precision Medicine (PRISM)
Lead Author
Arnaud Bayle
Collaborator
Gustave Roussy Cancer Center
Date | Time
Tuesday, April 12 | 1:30 PM – 5:00 PM
Abstract Number
3413/19